Clinical and Laboratory Markers in Determination of Treatment Modalities and Short-Term Prognosis in Patients with Traumatic Acute Subdural Hematoma: Original Study

Basit Öğe Kaydı
dc.authoridBAKAR, BULENT/0000-0002-6236-7647
dc.contributor.authorBakar, Bulent
dc.contributor.authorYuksel, Ulas
dc.contributor.authorOzdemir, Alemiddin
dc.contributor.authorBulut, Ibrahim Umud
dc.contributor.authorOgden, Mustafa
dc.date.accessioned2025-01-21T16:36:35Z
dc.date.available2025-01-21T16:36:35Z
dc.date.issued2023
dc.departmentKırıkkale Üniversitesi
dc.description.abstractObjective In patients with traumatic acute subdural hematoma (ASH), it has not been yet fully elucidated which patients can benefit from surgery or from clinical follow-up. This study was constructed to predict treatment modality and short-term prognosis in patients with ASH using their clinical, radiological, and biochemical laboratory findings during admission to hospital. Methods Findings of patients with ASH determined on their CT scan between 2015 and 2018 were evaluated. Patients were grouped in terms of ASH-FOL (patients followed-up without surgery, n =13), ASH-OP (patients treated surgically, n =10), and ASH-INOP (patients considered as inoperable, n = 5) groups. They also were divided into survived (n = 14) and nonsurvived (n = 14) groups. Results ASH developed as a result of fall from a height in 15 patients and traffic accidents in 13 patients. In deciding for surgery, it was determined that Glasgow coma scale (GCS) scores < 8, midline shift (MIS) level > 5 mm, MLS-hematoma thickness ratio > 0.22, leukocyte count > 12730 uL, and presence of anisocoria could be used as predictive markers. It was determined that GCS scores < 8, hematoma thickness value > 8 mm, and the presence of anisocoria could be considered as biomarkers in prediction of mortality likelihood. Conclusion It could be suggested that GCS scores, MLS level, MLS-hematoma thickness ratio, presence of anisocoria, and leukocyte count value could help in determination of the treatment modality in patients with ASH. Additionally, GCS scores, hematoma thickness value, and presence of anisocoria could each be used as a marker in the prediction of early-stage prognosis and mortality likelihood of these patients.
dc.identifier.doi10.1055/s-0041-1739475
dc.identifier.endpage100
dc.identifier.issn0973-0508
dc.identifier.issn2213-3739
dc.identifier.issue2
dc.identifier.startpage89
dc.identifier.urihttps://doi.org/10.1055/s-0041-1739475
dc.identifier.urihttps://hdl.handle.net/20.500.12587/24342
dc.identifier.volume20
dc.identifier.wosWOS:000727676400001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherGeorg Thieme Verlag Kg
dc.relation.ispartofIndian Journal of Neurotrauma
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectacute subdural hematoma; biochemistry; biomarker; prognosis
dc.titleClinical and Laboratory Markers in Determination of Treatment Modalities and Short-Term Prognosis in Patients with Traumatic Acute Subdural Hematoma: Original Study
dc.typeReview Article

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu